Menu
Back to Journals » Vascular Health and Risk Management » Volume 12
Review
PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab
| Total article views | Abstract views | HTML views | PDF downloads | Totals | |
|---|---|---|---|---|---|
| 13,112 | Dovepress* | 6,743 | 2,913+ | 2,168 | 9,656 |
| PubMed Central* | 0 | 3,456 | 1,030 | 3,456 | |
| Totals | 6,743 | 6,369 | 3,198 | 13,112 | |
|
*Since 9 May 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 3 | 5 |
View citations on PubMed Central and Google Scholar